主体导向免疫疗法,以加强治疗Mycobacterium结核病感染的治疗
Ren Fang1, Xingyue Yang1, Xiaotian Li1
1Weifang Key Laboratory of Respiratory Tract Pathogens and Drug Therapy, School of Life Science and Technology, Shandong Second Medical University, PR China.
International immunopharmacology
|September 7, 2025
概括
宿主导免疫疗法通过调节宿主免疫反应提供了一种对抗结核病 (TB) 的新方法. 这一战略在克服耐药性Mycobacterium结核病菌株和改善治疗结果方面显示出前景.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 由Mycobacterium tuberculosis (MTB) 引起的结核病 (TB) 是一个重大的全球卫生挑战,特别是在低收入和中等收入国家.
- 多耐药和广泛耐药的MTB菌株的兴起使传统的抗生素治疗变得复杂.
- 宿主导免疫疗法是传统结核病治疗的潜在辅助策略.
研究的目的:
- 审查当前关于宿主免疫反应对MTB感染的知识.
- 要总结最近在结核病的宿主向免疫治疗干预措施的进展.
- 讨论结核病管理中宿主导疗法的挑战和潜力.
主要方法:
- 对宿主免疫反应对Mycobacterium结核病的综合文献综述.
- 对当前针对宿主的免疫治疗策略的分析.
- 对免疫防御机制和治疗干预措施的评估.
主要成果:
- 主体导向疗法旨在调节宿主免疫系统,以提高病原体清除率.
- 这些方法可能会减少治疗时间,并限制MTB感染引起的组织损伤.
- 了解宿主-病原体相互作用是开发有效免疫疗法的关键.
结论:
- 宿主导疗法为结核病提供了耐药性独立的治疗选择.
- 将这些疗法与抗生素相结合可能会提高治疗效率并降低耐药性.
- 需要进行进一步的研究,以优化结核病的宿主导干预措施的传递系统,疗效和安全性.
相关概念视频
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis I
846
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
846
Pulmonary Tuberculosis IV
480
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
480
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis III
946
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
946


